Patent Assignment
Reel/Frame 024697/0120
Assignment of Assignor's Interest
Recorded: 2010-07-16
Pages: 24
Assignor
CODATHERAPEUTICS (NZ) LIMITED
Executed: 2006-04-15
Assignee
CODA THERAPEUTICS, INC.
10505 SORRENTO VALLEY RD, SUITE 395, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(6)
Formulations Comprising Antisense Nucleotides to Connexins
Patent:
7,098,190 →
Application:
09/890,363 →
Formulations Comprising Antisense Nucleotides to Connexins
Application:
11/447,599 →
Publication:
US 2007/0037765
Formulations Comprising Antisense Nucleotides to Connexins
Formulations Comprising Antisense Nucleotides to Connexins
Formulations comprising antisense nucleotides to connexins
Application:
11/512,730 →
Publication:
US 2007/0072819
Formulations Comprising Antisense Nucleotides to Connexins
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 2, 2006
From: BECKER, DAVID L.
To: CODA THERAPEUTICS, LTD.
Reel/Frame 017715/0322 →
Assignment of Assignor's Interest
Jun 20, 2006
From: BECKER, DAVID L.; GREEN, COLIN R.
To: CODA THERAPEUTICS, LTD.
Reel/Frame 017815/0898 →
Assignment of Assignor's Interest
Jul 16, 2010
From: BECKER, DAVID L.; GREEN, COLIN R.
To: CODA THERAPEUTICS, LTD.
Reel/Frame 024698/0318 →
Assignment of Assignor's Interest
Jan 9, 2013
From: CODA THERAPEUTICS (NZ) LIMITED
To: CODA THERAPEUTICS, INC.
Reel/Frame 029596/0782 →
Security Interest
Mar 6, 2015
From: CODA THERAPEUTICS, INC.
To: SQUARE 1 BANK
Reel/Frame 035102/0543 →
Change of Name
Apr 2, 2018
From: CODA THERAPEUTICS, INC.
To: OCUNEXUS THERAPEUTICS, INC.
Reel/Frame 045812/0664 →
Security Interest
Oct 17, 2019
From: EYEVANCE PHARMACEUTICALS LLC, AS GRANTOR
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 050751/0051 →
Release of Security Interest
Mar 9, 2020
From: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
To: OCUNEXUS THERAPEUTICS, INC. (F/K/A CODA THERAPEUTICS, INC.)
Reel/Frame 052054/0119 →
Termination and Release of Security Interest in Patents
Oct 9, 2020
From: HAYFIN SERVICES LLP
To: EYEVANCE PHARMACEUTICALS LLC
Reel/Frame 054172/0632 →